<DOC>
	<DOCNO>NCT01843621</DOCNO>
	<brief_summary>The purpose study find two dos dengue vaccine , five year period , child receive Dengue-003 study study third dose dengue give child - Do child still dengue antibody intend provide protection dengue infection one year two dos vaccine give study Dengue-003 ? - Were major medical problem appear dengue-like symptom one year vaccination ? - Will third dose dengue help stimulate part immune system intend help protect dengue infection ? - Is third dose safe first two dos ? - Are local reaction third dose vaccine similar child experience first two dos ?</brief_summary>
	<brief_title>A Phase I/II Trial Tetravalent Live Attenuated DEN Vaccine Flavivirus Antibody Naive Children</brief_title>
	<detailed_description />
	<mesh_term>Dengue</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Subjects receive two dos DEN vaccine Dengue003 study Subjects whoes parent sign informed consent form eligible participation five year followup study</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>9 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Dengue , Vaccine , Thailand</keyword>
</DOC>